UBS Group AG Raises Holdings in Hinge Health Inc. $HNGE

UBS Group AG lifted its holdings in shares of Hinge Health Inc. (NYSE:HNGE) by 168.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 356,701 shares of the company’s stock after purchasing an additional 223,980 shares during the period. UBS Group AG’s holdings in Hinge Health were worth $16,569,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also modified their holdings of HNGE. Marshall Wace LLP purchased a new position in shares of Hinge Health during the 2nd quarter worth approximately $367,000. Sei Investments Co. purchased a new position in Hinge Health in the 2nd quarter valued at approximately $869,000. Squarepoint Ops LLC purchased a new position in Hinge Health in the 2nd quarter valued at approximately $19,706,000. Raymond James Financial Inc. purchased a new position in Hinge Health in the 2nd quarter valued at approximately $3,258,000. Finally, Sandia Investment Management LP purchased a new position in Hinge Health in the 2nd quarter valued at approximately $657,000.

Wall Street Analyst Weigh In

Several research firms recently weighed in on HNGE. Stifel Nicolaus raised their price objective on Hinge Health from $59.00 to $67.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Freedom Capital raised Hinge Health to a “strong-buy” rating in a research note on Thursday, January 22nd. Citizens Jmp raised their price objective on Hinge Health from $65.00 to $80.00 and gave the company a “market outperform” rating in a research note on Wednesday, May 6th. Royal Bank Of Canada raised their price objective on Hinge Health from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 6th. Finally, Needham & Company LLC raised their price objective on Hinge Health from $59.00 to $63.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $67.40.

Hinge Health Stock Performance

Hinge Health stock opened at $55.17 on Wednesday. The stock has a fifty day moving average of $43.58 and a two-hundred day moving average of $44.12. The company has a market capitalization of $4.35 billion and a price-to-earnings ratio of -4.47. Hinge Health Inc. has a fifty-two week low of $30.08 and a fifty-two week high of $62.18.

Hinge Health (NYSE:HNGE) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.33. The company had revenue of $182.31 million during the quarter. Hinge Health had a negative return on equity of 310.62% and a negative net margin of 78.95%.The business’s quarterly revenue was up 47.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.30 EPS. On average, analysts forecast that Hinge Health Inc. will post 0.78 EPS for the current fiscal year.

Insider Buying and Selling

In other Hinge Health news, President James Pursley sold 15,000 shares of the firm’s stock in a transaction on Monday, March 23rd. The stock was sold at an average price of $42.26, for a total transaction of $633,900.00. Following the completion of the transaction, the president owned 732,104 shares of the company’s stock, valued at approximately $30,938,715.04. This trade represents a 2.01% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Daniel Antonio Perez sold 166,665 shares of the firm’s stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $40.26, for a total value of $6,709,932.90. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 648,576 shares of company stock worth $30,122,850. 18.92% of the stock is currently owned by corporate insiders.

About Hinge Health

Hinge Health (NYSE: HNGE) is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company’s platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.